LanZhou Foci Pharmaceutical Co.,Ltd.
002644.SZ
Price:
$9.52
Market Cap:
$4.86B
LanZhou Foci Pharmaceutical Co.,Ltd., a pharmaceutical company, manufactures and sells traditional Chinese medicines in China. It offers its products in various dosage forms, including pills, tablets, capsules, and granules under the Min Shan and Foci brands. The company also engages in researching activities for the development of new herbal drugs. It also exports its products to approximately 27 countries, which include the United States, Canada, Japan, Australia, Russia, Ukraine, Singapore, Indonesia, Thailand, Malaysia, New Zealand, Hong Kong, etc. The company was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. is a subsidiary of Lanzhou Foci Pharmace...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-12-22
Stock Exchange
SHZ
Ticker
002644.SZ
PE Ratio
[79.33]
ROE
[3.27%]
Current Ratio
[3.10]
Dividend Yield
[0.13%]
Enterprise Value
[4.46B]
Dividend History
The ROE as of December 2025 (TTM) for LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) is 3.27%
According to LanZhou Foci Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is 3.27%. This represents a change of 299.14% compared to the average of 0.82% of the last 4 quarters.
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) Historical ROE (quarterly & annually)
How has 002644.SZ ROE performed in the past?
The mean historical ROE of LanZhou Foci Pharmaceutical Co.,Ltd. over the last ten years is 4.96%. The current 3.27% ROE has changed -34.13% with respect to the historical average. Over the past ten years (40 quarters), 002644.SZ's ROE was at its highest in in the June 2020 quarter at 5.34%. The ROE was at its lowest in in the December 2019 quarter at -0.12%.
Average
4.96%
Median
4.89%
Minimum
3.36%
Maximum
6.83%
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) ROE by Quarter and Year
Discovering the peaks and valleys of LanZhou Foci Pharmaceutical Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 44.50%
Maximum Annual ROE = 6.83%
Minimum Annual Increase = -39.22%
Minimum Annual ROE = 3.36%
| Year | ROE | Change |
|---|---|---|
| 2024 | 3.36% | -12.82% |
| 2023 | 3.85% | -39.22% |
| 2022 | 6.33% | 9.66% |
| 2021 | 5.78% | -15.40% |
| 2020 | 6.83% | 44.50% |
| 2019 | 4.73% | -6.66% |
| 2018 | 5.06% | -7.14% |
| 2017 | 5.45% | 15.48% |
| 2016 | 4.72% | 35.60% |
| 2015 | 3.48% | -26.14% |
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) Average ROE
How has 002644.SZ ROE performed in the past?
The current ROE of LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.51%
5-year avg
5.23%
10-year avg
4.96%
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) ROE vs. Peers
How is 002644.SZ’s ROE compared to its peers?
LanZhou Foci Pharmaceutical Co.,Ltd.’s ROE is less than Jinhe Biotechnology Co. Ltd. (5.45%), less than Yabao Pharmaceutical Group Co., Ltd (7.80%), greater than Wuhan Hiteck Biological Pharma Co.,Ltd (-8.03%), less than Jinling Pharmaceutical Company Limited (0.99%), less than ZhuZhou QianJin Pharmaceutical Co.,Ltd (10.08%), greater than Harbin Medisan Pharmaceutical Co., Ltd. (-9.30%), less than Tibet Weixinkang Medicine Co., Ltd. (15.13%), greater than Zhuhai Rundu Pharmaceutical Co., Ltd. (-4.71%), greater than Zhejiang Starry Pharmaceutical Co.,Ltd. (-1.11%), less than Beijing Beilu Pharmaceutical Co., Ltd (1.84%),
| Company | ROE | Market cap |
|---|---|---|
| 5.45% | $4.65B | |
| 7.80% | $4.65B | |
| -8.03% | $3.71B | |
| 0.99% | $4.80B | |
| 10.08% | $4.28B | |
| -9.30% | $4.15B | |
| 15.13% | $4.75B | |
| -4.71% | $4.18B | |
| -1.11% | $4.15B | |
| 1.84% | $4.50B |
Build a custom stock screener for LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LanZhou Foci Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like LanZhou Foci Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is LanZhou Foci Pharmaceutical Co.,Ltd.'s ROE?
How is the ROE calculated for LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)?
What is the highest ROE for LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)?
What is the 3-year average ROE for LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)?
What is the 5-year average ROE for LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)?
How does the current ROE for LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) compare to its historical average?